Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Efficacy, and Long-Term Outcomes of Intralesional Bleomycin Injection as an Adjunctive Therapy for Pediatric Lymphatic Malformations: A Retrospective Study on Cosmetic and Health-Related Quality of Life Improvements.

NCT06943703 is registered in ClinicalTrials.gov with National Children's Hospital, Vietnam as lead sponsor.

NCT NCT06943703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06943703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Efficacy, and Long-Term Outcomes of Intralesional Bleomycin Injection as an Adjunctive Therapy for Pediatric Lymphatic Malformations: A Retrospective Study on Cosmetic and Health-Related Quality of Life Improvements.
Lead sponsor
National Children's Hospital, Vietnam
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
February 4, 2025
Enrollment
809 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphangioma, lymphatic malformations